AKBA Earnings & Financial Statements - Akebia Therapeutics, Inc. logo

AKBA Earnings & Financial Statements

Akebia Therapeutics, Inc.

$0.42
-$0.00(-1.09%)
32
Overall
40
Value
18
Tech
39
Quality
How is this score calculated?
Market Cap
$115.98M
Volume
323.04K
52W Range
$0.36 - $1.84
Target Price
$3.25

AKBA earnings and financial statements: Akebia Therapeutics, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.

AKBA Annual Financial Statements

AKBA income statement
Fiscal year20252024202320222021
Revenue$236.20M$160.18M$194.62M$292.48M$213.58M
Cost of revenue$39.46M$27.14M$38.11M$85.57M$150.67M
Operating income$23.50M-$50.47M-$46.26M-$80.78M-$265.32M
EBITDA$21.73M-$13.76M-$4.05M-$43.26M-$228.37M
Net income-$5.34M-$69.41M-$51.92M-$94.23M-$282.02M
EPS (diluted)$-0.02$-0.33$-0.28$-0.51$-1.70
AKBA balance sheet
Fiscal year20252024202320222021
Total assets$376.56M$220.67M$241.70M$356.05M$525.60M
Total liabilities$343.95M$269.86M$272.29M$350.82M$449.09M
Shareholders’ equity$32.61M-$49.19M-$30.58M$5.23M$76.46M
Cash and equivalents$184.84M$51.87M$42.92M$90.47M$149.80M
Long-term debt$48.25M$42.24M$26.13M$63.04M$33.70M
AKBA cash flow statement
Fiscal year20252024202320222021
Operating cash flow$67.99M-$40.66M-$23.38M-$73.15M-$252.98M
Capital expenditure-$119.0K-$33.0K--$114.0K-$59.0K
Free cash flow$67.70M-$40.69M-$23.38M-$73.27M-$253.04M
ABCD
1SymbolPriceChangeVol
2AKBA$0.42-1.1%323.04K
3
4
5
6

Get Akebia Therapeutics, Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.